0
USD
U.S. (TOLL FREE)
+1 (425) 388-2538
Automative

0
U.S. (TOLL FREE)
+1 (425) 388-2538

Chronic Back Pain - Pipeline Insight, 2019

Published Date: March 2019
|
Report Code: DELV-Pipe-227
Home | Category |Health |Health Conditions |Pain Management
Chronic Back Pain Pipeline Insight 2019

Chronic Back Pain - Pipeline Insight, 2019

Code: DELV-Pipe-227
Report
March 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

"Chronic Back Pain - Pipeline Insight, 2019” report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Chronic Back Pain development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental Stages:
• Clinical
• Non-clinical
• Inactive: Discontinued and/or Dormant

Descriptive coverage of pipeline development activities for Chronic Back Pain
Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Pipeline Therapeutics assessment of products for Chronic Back Pain
The report assesses the active Chronic Back Pain pipeline products by developmental stage, product type, molecule type, and administration route.

Methodology
Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight’s team of industry experts.
Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

Scope of the report
• The report provides a snapshot of the pipeline development for the Chronic Back Pain
• The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Chronic Back Pain
• The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Chronic Back Pain
• The report also covers the dormant and discontinued pipeline projects related to the Chronic Back Pain

Reasons to Buy
• Establish comprehensive understanding of the pipeline activity across this Chronic Back Pain to formulate effective R&D strategies
• Gather information of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine
• Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Chronic Back Pain therapeutics
• Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress

1. Report Introduction
2. Chronic Back Pain Overview
3. Pipeline Therapeutics
• An Overview of Pipeline Products for Chronic Back Pain
4. Comparative Analysis
5. Products in Clinical Stage
5.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
6. Products in Pre-Clinical and Discovery Stage
6.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
7. Therapeutic Assessment
• Assessment by Route of Administration
• Assessment by Stage and Route of Administration
• Assessment by Molecule Type
• Assessment by Stage and Molecule Type
8. Inactive Products
8.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight

LIST OF TABLES :

Table 1: Total Products for Chronic Back Pain
Table 2: Products in Clinical Stage
Table 3: Products in Non-clinical Stage
Table 4: Assessment by Route of Administration
Table 5: Assessment by Stage and Route of Administration
Table 6: Assessment by Molecule Type
Table 7: Assessment by Stage and Molecule Type
Table 8: Inactive Products

LIST OF FIGURES :

Figure 1: Total Products for Chronic Back Pain
Figure 2: Products in Clinical Stage
Figure 3: Products in Non-clinical Stage
Figure 4: Assessment by Route of Administration
Figure 5: Assessment by Stage and Route of Administration
Figure 6: Assessment by Molecule Type
Figure 7: Assessment by Stage and Molecule Type
Figure 8: Inactive Products

 

"Chronic Back Pain - Pipeline Insight, 2019” report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Chronic Back Pain development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental Stages:
• Clinical
• Non-clinical
• Inactive: Discontinued and/or Dormant

Descriptive coverage of pipeline development activities for Chronic Back Pain
Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Pipeline Therapeutics assessment of products for Chronic Back Pain
The report assesses the active Chronic Back Pain pipeline products by developmental stage, product type, molecule type, and administration route.

Methodology
Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight’s team of industry experts.
Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

Scope of the report
• The report provides a snapshot of the pipeline development for the Chronic Back Pain
• The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Chronic Back Pain
• The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Chronic Back Pain
• The report also covers the dormant and discontinued pipeline projects related to the Chronic Back Pain

Reasons to Buy
• Establish comprehensive understanding of the pipeline activity across this Chronic Back Pain to formulate effective R&D strategies
• Gather information of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine
• Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Chronic Back Pain therapeutics
• Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress

Read More

1. Report Introduction
2. Chronic Back Pain Overview
3. Pipeline Therapeutics
• An Overview of Pipeline Products for Chronic Back Pain
4. Comparative Analysis
5. Products in Clinical Stage
5.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
6. Products in Pre-Clinical and Discovery Stage
6.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
7. Therapeutic Assessment
• Assessment by Route of Administration
• Assessment by Stage and Route of Administration
• Assessment by Molecule Type
• Assessment by Stage and Molecule Type
8. Inactive Products
8.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight

Read More

LIST OF TABLES :

Table 1: Total Products for Chronic Back Pain
Table 2: Products in Clinical Stage
Table 3: Products in Non-clinical Stage
Table 4: Assessment by Route of Administration
Table 5: Assessment by Stage and Route of Administration
Table 6: Assessment by Molecule Type
Table 7: Assessment by Stage and Molecule Type
Table 8: Inactive Products

LIST OF FIGURES :

Figure 1: Total Products for Chronic Back Pain
Figure 2: Products in Clinical Stage
Figure 3: Products in Non-clinical Stage
Figure 4: Assessment by Route of Administration
Figure 5: Assessment by Stage and Route of Administration
Figure 6: Assessment by Molecule Type
Figure 7: Assessment by Stage and Molecule Type
Figure 8: Inactive Products

 

Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$1250
This license allows only one user to access the PDF.

Site License

Electronic (PDF)
$2500
This license allows all the users of an enterprise residing in one location to access the PDF

Enterprise License

Electronic (PDF)
$4000
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)

RELATED REPORTS

U S Topical Pain Relief Market by Therapeutic Class Non Opioids and Opioids Type Prescription Pain Relief and Over the Counter Pain Relief Formulation Cream Gel Spray Patch and Others and Distribution Channel Pharmacies Drug Stores E commerce and Retail Grocery Stores Opportunity Analysis and Industry Forecast 2018 2025
U S Topical Pain Relief Market by Therapeutic Class Non Opioids and Opioids Type Prescription Pain Relief and Over the Counter Pain Relief Formulation Cream Gel Spray Patch and Others and Distribution Channel Pharmacies Drug Stores E commerce and Retail Grocery Stores Opportunity Analysis and Industry Forecast 2018 2025

U.S. Topical Pain Relief Market by Therapeutic Class (Non-Opioids and Opioids), Type (Prescription Pain Relief and Over-the-Counter Pain Relief), Formulation (Cream, Gel, Spray, Patch, and Others), and Distribution Channel (Pharmacies & Drug Stores, E-commerce, and Retail & Grocery Stores): Opportunity Analysis and Industry Forecast, 2018-2025

120 Pages
Type: Report
Code: ALLI-Auto-0T358
Wed Nov 20 00:00:00 UTC 2019

Add to Cart

Topical Pain Relief Market by Therapeutic Class Non Opioids and Opioids Type Prescription Pain Relief and Over the Counter Pain Relief Formulation Cream Gel Spray Patch and Others and Distribution Channel Pharmacies Drug Stores e Commerce and Retail Grocery Stores Global Opportunity Analysis and Industry Forecast 2018 2025
Topical Pain Relief Market by Therapeutic Class Non Opioids and Opioids Type Prescription Pain Relief and Over the Counter Pain Relief Formulation Cream Gel Spray Patch and Others and Distribution Channel Pharmacies Drug Stores e Commerce and Retail Grocery Stores Global Opportunity Analysis and Industry Forecast 2018 2025

Topical Pain Relief Market by Therapeutic Class (Non-Opioids and Opioids), Type (Prescription Pain Relief and Over-the-Counter Pain Relief), Formulation (Cream, Gel, Spray, Patch, and Others) and Distribution Channel (Pharmacies & Drug Stores, e-Commerce, and Retail & Grocery Stores) - Global Opportunity Analysis and Industry Forecast, 2018-2025

120 Pages
Type: Report
Code: ALLI-Auto-0L257
Tue Nov 19 00:00:00 UTC 2019

Add to Cart

Migraine Drugs Market by Type Abortive Medicine and Preventive Medicine Route of Administration Oral Injection and Others and Distribution Channel Hospital based Pharmacies Retail Pharmacies and Online Pharmacies Global Opportunity Analysis and Industry Forecast 2018 2025
Migraine Drugs Market by Type Abortive Medicine and Preventive Medicine Route of Administration Oral Injection and Others and Distribution Channel Hospital based Pharmacies Retail Pharmacies and Online Pharmacies Global Opportunity Analysis and Industry Forecast 2018 2025

Migraine Drugs Market by Type (Abortive Medicine and Preventive Medicine), Route of Administration (Oral, Injection, and Others), and Distribution Channel (Hospital-based Pharmacies, Retail Pharmacies and Online Pharmacies) - Global Opportunity Analysis and Industry Forecast, 2018-2025

120 Pages
Type: Report
Code: ALLI-Auto-4Y268
Tue Nov 19 00:00:00 UTC 2019

Add to Cart

 Pain Management Drugs Market by Drug Class NSAIDs Anesthetics Anticonvulsants Antimigraine Agents Antidepressants Opioids Tramadol Hydrocodone Oxycodone and Others and Nonnarcotic Analgesics and Indication Arthritic Pain Neuropathic Pain Cancer Pain Chronic Back Pain Postoperative Pain Migraine and Fibromyalgia Global Opportunity Analysis and Industry Forecast 2017 2023
Pain Management Drugs Market by Drug Class NSAIDs Anesthetics Anticonvulsants Antimigraine Agents Antidepressants Opioids Tramadol Hydrocodone Oxycodone and Others and Nonnarcotic Analgesics and Indication Arthritic Pain Neuropathic Pain Cancer Pain Chronic Back Pain Postoperative Pain Migraine and Fibromyalgia Global Opportunity Analysis and Industry Forecast 2017 2023

Pain Management Drugs Market by Drug Class (NSAIDs, Anesthetics, Anticonvulsants, Antimigraine Agents, Antidepressants, Opioids [Tramadol, Hydrocodone, Oxycodone, and Others], and Nonnarcotic Analgesics) and Indication (Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Back Pain, Postoperative Pain, Migraine, and Fibromyalgia) - Global Opportunity Analysis and Industry Forecast, 2017-2023

120 Pages
Type: Report
Code: ALLI-Auto-2X182
Tue Nov 19 00:00:00 UTC 2019

Add to Cart

0 Items
X
No items in the cart.
$0.0